MBXBF (Microbix Biosystems) Cyclically Adjusted FCF per Share: $-0.01 (As of Mar. 2026)


MBXBF Microbix Biosystems Inc MBXBF
55 GF Score
Price $0.22
GF Value $0.18
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Cyclically Adjusted FCF per Share?

Microbix Biosystems MBXBF -0.41% 55 Cyclically Adjusted FCF per Share is $-0.01 as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 55/100 and a GF Value™ of $0.18 (Modestly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Microbix Biosystems's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.01 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Microbix Biosystems was 26.30% per year. The lowest was -10.10% per year. And the median was 0.00% per year.

As of today (2026-07-07), Microbix Biosystems's current stock price is $0.215. Microbix Biosystems's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-0.01. Microbix Biosystems's Cyclically Adjusted Price-to-FCF of today is .


Microbix Biosystems  (OTCPK:MBXBF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Microbix Biosystems Cyclically Adjusted FCF per Share Related Terms


Microbix Biosystems Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Cyclically Adjusted FCF per Share Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.01 -0.02 -0.01 0.00

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 0.00 -0.01 -0.01

MBXBF vs VRTX, REGN, ALNY: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Microbix Biosystems's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Cyclically Adjusted Price-to-FCF falls into.


MBXBF
55GF Score
Microbix Biosystems Inc MBXBF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbix Biosystems's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.003/132.2623*132.2623
=-0.003

Current CPI (Mar. 2026) = 132.2623.

Microbix Biosystems Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.002 102.002 0.003
201609 0.001 101.765 0.001
201612 0.001 101.449 0.001
201703 -0.002 102.634 -0.003
201706 0.001 103.029 0.001
201709 -0.004 103.345 -0.005
201712 -0.016 103.345 -0.020
201803 0.001 105.004 0.001
201806 -0.002 105.557 -0.003
201809 0.002 105.636 0.003
201812 0.000 105.399 0.000
201903 -0.003 106.979 -0.004
201906 -0.002 107.690 -0.002
201909 0.002 107.611 0.002
201912 0.001 107.769 0.001
202003 -0.007 107.927 -0.009
202006 0.003 108.401 0.004
202009 -0.003 108.164 -0.004
202012 -0.003 108.559 -0.004
202103 0.004 110.298 0.005
202106 -0.005 111.720 -0.006
202109 0.006 112.905 0.007
202112 -0.002 113.774 -0.002
202203 0.003 117.646 0.003
202206 0.013 120.806 0.014
202209 -0.006 120.648 -0.007
202212 -0.005 120.964 -0.005
202303 -0.008 122.702 -0.009
202306 0.010 124.203 0.011
202309 -0.008 125.230 -0.008
202312 0.007 125.072 0.007
202403 0.001 126.258 0.001
202406 0.002 127.522 0.002
202409 0.003 127.285 0.003
202412 0.003 127.364 0.003
202503 0.004 129.181 0.004
202506 -0.011 129.892 -0.011
202509 0.000 130.287 0.000
202512 -0.014 130.366 -0.014
202603 -0.003 132.262 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.01 mean?
Microbix Biosystems (MBXBF) has a Cyclically Adjusted FCF per Share of $-0.01 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Cyclically Adjusted FCF per Share too high?
Microbix Biosystems' current Cyclically Adjusted FCF per Share is $-0.01. Overall, Microbix Biosystems has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Microbix Biosystems' Cyclically Adjusted FCF per Share of $-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Cyclically Adjusted FCF per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.22 — trading 19.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $-0.01. Microbix Biosystems' overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Cyclically Adjusted FCF per Share is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 19.4% above its estimated GF Value™ of $0.18. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Cyclically Adjusted FCF per Share: $-0.01
  • GF Value™: $0.18 vs. price of $0.22 (19.4% above fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
55GF Score

Get the complete analysis for MBXBF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.18
GF Value